1. Home
  2. HRTG vs VOR Comparison

HRTG vs VOR Comparison

Compare HRTG & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Insurance Holdings Inc.

HRTG

Heritage Insurance Holdings Inc.

HOLD

Current Price

$30.68

Market Cap

898.0M

Sector

Finance

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

HOLD

Current Price

$14.45

Market Cap

767.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRTG
VOR
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
898.0M
767.4M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
HRTG
VOR
Price
$30.68
$14.45
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$33.50
$45.33
AVG Volume (30 Days)
255.3K
1.3M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
214.43
N/A
EPS
6.32
N/A
Revenue
$847,330,000.00
N/A
Revenue This Year
$7.50
N/A
Revenue Next Year
$6.74
N/A
P/E Ratio
$4.70
N/A
Revenue Growth
3.71
N/A
52 Week Low
$16.83
$0.13
52 Week High
$31.98
$49.95

Technical Indicators

Market Signals
Indicator
HRTG
VOR
Relative Strength Index (RSI) 73.06 46.41
Support Level $25.28 $11.74
Resistance Level $31.98 $14.73
Average True Range (ATR) 1.06 1.04
MACD 0.42 -0.25
Stochastic Oscillator 98.98 23.90

Price Performance

Historical Comparison
HRTG
VOR

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally. Company operates in Alabama, California, Connecticut, Delaware, Florida, Georgia, Hawaii, Maryland, Massachusetts, Mississippi, New Jersey, New York, North Carolina, Rhode Island, South Carolina.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: